Table 4.
Differentially Expressed Transcripts at Flare and After Treatment in Non-Responders
| Transcripts Differentially-Expressed Compared to Normal Kidney at Biopsy 1 |
Change in Transcript Expression from Biopsy 1 to Biopsy 2 |
Transcripts that Become Differentially-Expressed Compared to Normal After Treatment at Biopsy 2 |
|||||
|---|---|---|---|---|---|---|---|
| Gene | Fold Change1 | P2 | Percent Change3 | P4 | Gene | Fold Change1 | P2 |
| C1QB | 4.52 | 0.0000 | −38% | 0.04 | CFD | 8.01 | 0.0002 |
| MX1 | 3.90 | 0.004 | 67% | 0.29 | CCL19 | 5.94 | 0.0006 |
| ITGAL | 3.73 | 0.0001 | 66% | 0.09 | C3 | 4.96 | 0.001 |
| ITGB2 | 3.48 | 0.0000 | 25% | 0.39 | SELL | 4.22 | 0.003 |
| CYBB | 3.41 | 0.0000 | 59% | 0.07 | CX3CR1 | 3.74 | 0.0000 |
| FCER1G | 3.41 | 0.0004 | 33% | 0.27 | CASP1 | 3.24 | 0.0000 |
| FCGR3A | 3.35 | 0.006 | 35% | 0.48 | IFITM1 | 3.09 | 0.006 |
| STAT1 | 3.09 | 0.0008 | 39% | 0.25 | ITGAX | 3.08 | 0.0007 |
| C1S | 3.00 | 0.0000 | 10% | 0.60 | B2M | 2.87 | 0.009 |
| BST2 | 2.88 | 0.0000 | 8% | 0.75 | CD40 | 2.87 | 0.009 |
| C1R | 2.79 | 0.001 | −5% | 0.85 | LCK | 2.82 | 0.0005 |
| FN1 | 2.75 | 0.001 | −25% | 0.36 | LCP2 | 2.77 | 0.0001 |
| LAIR1 | 2.68 | 0.0000 | −5% | 0.78 | C2 | 2.77 | 0.008 |
| TGFBI | 2.62 | 0.002 | 17% | 0.59 | SLAMF7 | 2.76 | 0.008 |
| KIR2DL3 | 2.51 | 0.009 | −50% | 0.04 | IL1RN | 2.73 | 0.001 |
| GZMA | 2.48 | 0.002 | 24% | 0.34 | IRF8 | 2.72 | 0.005 |
| HLA-B | 2.44 | 0.0001 | 29% | 0.27 | TAGAP | 2.66 | 0.009 |
| HLA-DRB3 | 2.44 | 0.002 | 37% | 0.28 | IFI16 | 2.66 | 0.0000 |
| LILRA3 | 2.39 | 0.001 | 21% | 0.46 | JAK3 | 2.61 | 0.01 |
| IRF7 | 2.23 | 0.009 | 34% | 0.36 | FCGR2B | 2.61 | 0.003 |
| HLA-A | 2.23 | 0.004 | 3% | 0.90 | CD5 | 2.55 | 0.009 |
| BTK | 2.20 | −1% | 0.10 | PTPN6 | 2.42 | ||
| 0.001 | 0.0001 | ||||||
| PTPRC | 2.20 | 0.01 | 115% | 0.01 | ZAP70 | 2.34 | 0.006 |
| CSF2RB | 2.19 | 0.002 | 85% | 0.01 | NCF4 | 2.34 | 0.0009 |
| TNF | 2.18 | 0.0009 | 48% | 0.15 | TGFB1 | 2.34 | 0.0002 |
| CD6 | 2.05 | 0.005 | −10% | 0.64 | ITGAM | 2.27 | 0.0007 |
| MR1 | 0.50 | 0.001 | 10% | 0.68 | GZMB | 2.26 | 0.003 |
| NOS2 | 0.49 | 0.008 | 45% | 0.10 | ARHGDIB | 2.26 | 0.0000 |
| CEBPB | 0.48 | 0.002 | 13% | 0.58 | CD24 | 2.25 | 0.002 |
| ITGA6 | 0.46 | 0.0006 | −13% | 0.51 | TLR1 | 2.21 | 0.0000 |
| IGF2R | 0.45 | 0.006 | −9% | 0.74 | IKZF1 | 2.19 | 0.008 |
| IL6R | 0.44 | 0.0001 | 4% | 0.88 | LILRB1 | 2.18 | 0.007 |
| C9 | 0.43 | 0.0007 | −8% | 0.71 | PRF1 | 2.15 | 0.003 |
| ICOSLG | 0.43 | 0.0001 | −35% | 0.03 | CXCL13 | 2.11 | 0.008 |
| TFRC | 0.42 | 0.0002 | −23% | 0.21 | CD97 | 2.11 | 0.001 |
| CR1 | 0.42 | 0.002 | 33% | 0.32 | STAT2 | 2.07 | 0.0000 |
| BST1 | 0.41 | 0.001 | 32% | 0.29 | NFATC1 | 0.50 | 0.004 |
| SELE | 0.40 | 0.0008 | 15% | 0.61 | LTB4R2 | 0.50 | 0.003 |
| CISH | 0.38 | 0.0000 | −6% | 0.73 | MAPKAPK2 | 0.49 | 0.001 |
| CDKN1 A | 0.30 | 0.0000 | −3% | 0.90 | GPI | 0.49 | 0.001 |
| RORC | 0.22 | 0.0000 | −6% | 0.81 | IL8 | 0.47 | 0.004 |
| DPP4 | 0.22 | 0.003 | −17% | 0.67 | PDGFB | 0.46 | 0.003 |
| NFIL3 | 0.21 | 0.0000 | 4% | 0.90 | TRAF4 | 0.46 | 0.002 |
| MME | 0.15 | 0.0000 | −5% | 0.88 | CTNNB1 | 0.45 | 0.0002 |
| CR2 | 0.12 | 0.0000 | 76% | 0.17 | CRADD | 0.45 | 0.0006 |
| TAL1 | 0.45 | 0.001 | |||||
| CD8B | 0.44 | 0.003 | |||||
| NFKBIA | 0.44 | 0.0000 | |||||
| TOLLIP | 0.40 | 0.001 | |||||
| CTSC | 0.40 | 0.0002 | |||||
| CD274 | 0.40 | 0.009 | |||||
| C5 | 0.38 | 0.0000 | |||||
| KIT | 0.37 | 0.002 | |||||
| IL12RB1 | 0.35 | 0.008 | |||||
| BLNK | 0.35 | 0.0003 | |||||
| C6 | 0.35 | 0.0000 | |||||
| CD81 | 0.34 | 0.008 | |||||
| C1QBP | 0.34 | 0.003 | |||||
| CEACAM6 | 0.33 | 0.005 | |||||
| CFI | 0.29 | 0.0001 | |||||
| CX3CL1 | 0.28 | 0.0001 | |||||
| VTN | 0.25 | 0.0001 | |||||
| ABCB1 | 0.25 | 0.0005 | |||||
| DEFB1 | 0.23 | 0.002 | |||||
| SPP1 | 0.17 | 0.001 | |||||
| FKBP5 | 0.14 | 0.0004 | |||||
Transcript expression in LN compared to normal controls
LN versus normal; p≤0.01 and fold change compared to normal >2 or <0.5 to be considered differentially expressed
Transcript expression from biopsy 1 to biopsy 2
Biopsy 1 versus biopsy 2